IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,175,000 | +12.9% | 111,807 | -3.4% | 0.01% | +25.0% |
| Q4 2017 | $1,927,000 | -19.2% | 115,727 | -1.5% | 0.00% | -20.0% |
| Q3 2017 | $2,386,000 | +13.9% | 117,520 | -9.6% | 0.01% | +25.0% |
| Q2 2017 | $2,094,000 | +14.7% | 130,032 | -9.9% | 0.00% | 0.0% |
| Q1 2017 | $1,825,000 | -8.8% | 144,276 | -4.4% | 0.00% | 0.0% |
| Q4 2016 | $2,000,000 | -45.5% | 150,976 | -2.6% | 0.00% | -50.0% |
| Q3 2016 | $3,673,000 | -17.1% | 154,976 | +0.8% | 0.01% | -20.0% |
| Q2 2016 | $4,432,000 | -9.1% | 153,776 | +1.0% | 0.01% | 0.0% |
| Q1 2016 | $4,877,000 | -14.1% | 152,297 | +14.7% | 0.01% | -28.6% |
| Q4 2015 | $5,680,000 | +23.3% | 132,825 | +1.5% | 0.01% | +16.7% |
| Q3 2015 | $4,607,000 | -23.4% | 130,854 | -0.1% | 0.01% | -20.0% |
| Q2 2015 | $6,013,000 | -0.0% | 130,954 | +2.1% | 0.02% | +7.1% |
| Q1 2015 | $6,014,000 | +45.3% | 128,315 | -1.8% | 0.01% | +40.0% |
| Q4 2014 | $4,138,000 | +34.9% | 130,615 | +1.0% | 0.01% | +25.0% |
| Q3 2014 | $3,067,000 | -20.1% | 129,362 | +1.1% | 0.01% | -20.0% |
| Q2 2014 | $3,837,000 | +16.7% | 127,928 | +2.8% | 0.01% | +11.1% |
| Q1 2014 | $3,287,000 | +5.4% | 124,428 | +0.3% | 0.01% | +12.5% |
| Q4 2013 | $3,118,000 | +23.5% | 124,028 | +0.7% | 0.01% | 0.0% |
| Q3 2013 | $2,525,000 | +6.0% | 123,128 | +3.2% | 0.01% | 0.0% |
| Q2 2013 | $2,381,000 | +32.4% | 119,326 | +2.5% | 0.01% | +33.3% |
| Q1 2013 | $1,798,000 | – | 116,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |